CAS 546-06-5|Conessine
| Common Name | Conessine | ||
|---|---|---|---|
| CAS Number | 546-06-5 | Molecular Weight | 356.588 |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 450.4±45.0 °C at 760 mmHg |
| Molecular Formula | C24H40N2 | Melting Point | 126-127ºC |
| MSDS | ChineseUSA | Flash Point | 199.6±16.5 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | conessine |
|---|---|
| Synonym | More Synonyms |
Conessine BiologicalActivity
| Description | Conessine, a steroidal alkaloid, is a potent and selective histamine H3 receptor antagonist with Kis of 5.4, 6.0, 5.7 and 25 nM for human, dog, guinea pig, and rat H H3 receptor, respectively. Anti-malarial activity[1]. |
|---|---|
| Related Catalog | Signaling Pathways >>Immunology/Inflammation >>Histamine ReceptorResearch Areas >>InfectionSignaling Pathways >>GPCR/G Protein >>Histamine Receptor |
| Target | H3 Receptor:5.4 nM (Ki) rat H3 receptor:25 nM (Ki) Guinea pig H3 Receptor:6.0 nM (Ki) Dog H3 Receptor:5.7 nM (Ki) |
| References | [1]. Santora VJ, et al. A new family of H3 receptor antagonists based on the natural product Conessine. Bioorg Med Chem Lett. 2008;18(4):1490-1494. [2]. Kim H, et al. Conessine treatment reduces dexamethasone-induced muscle atrophy by regulating MuRF1 and atrogin-1 expression [published online ahead of print, 2018 Feb 1]. J Microbiol Biotechnol. 2018;10.4014.jmb.1711.11009. |
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 450.4±45.0 °C at 760 mmHg |
| Melting Point | 126-127ºC |
| Molecular Formula | C24H40N2 |
| Molecular Weight | 356.588 |
| Flash Point | 199.6±16.5 °C |
| Exact Mass | 356.319153 |
| PSA | 6.48000 |
| LogP | 5.71 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.564 |
| InChIKey | GPLGAQQQNWMVMM-MYAJQUOBSA-N |
| SMILES | CC1C2CCC3C4CC=C5CC(N(C)C)CCC5(C)C4CCC32CN1C |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 208 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 58,373,1936
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 138 mg/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea
- REFERENCE :
- JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 58,373,1936
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
| RTECS | GK7621000 |
Articles23
More Articles| [New orientation and new therapeutic weapons in the therapy of intestinal amebiasis]. Minerva Med. 43(59-60) , 129-33, (1952) | |
| Highly enantioselective construction of fused pyrrolidine systems that contain a quaternary stereocenter: concise formal synthesis of (+)-conessine. Angew. Chem. Int. Ed. Engl. 43(19) , 2543-6, (2004) | |
| High-performance thin layer chromatography method for estimation of conessine in herbal extract and pharmaceutical dosage formulations. J. Pharm. Biomed. Anal. 46(2) , 391-4, (2008) A new, simple, sensitive, precise and robust high-performance thin layer chromatographic (HPTLC) method was developed for the estimation of conessine in herbal extracts and pharmaceutical dosage forms... |
Synonyms
| 3β-(Dimethylamino)con-5-enine |
| 3-β-(Dimethylamino)con-5-enine |
| CONESSIN |
| Conessine |
| Con-5-enin-3-amine, N,N-dimethyl-, (3β)- |
| (3S,3aS,5aS,5bR,9S,11aR,11bS,13aR)-N,N,2,3,11a-Pentamethyl-2,3,3a,4,5,5a,5b,6,8,9,10,11,11a,11b,12,13-hexadecahydro-1H-naphtho[2',1':4,5]indeno[1,7a-c]pyrrol-9-amine |
| Konessin |
| ROGUESSINE |
| Conessine,N,N-Dimethyl-con-5-enin-3-amine |
| (3β)-N,N-Dimethylcon-5-enin-3-amine |
| ROQUESSINE |
| Wrightine |
| NERVINE |
| 3β-(Dimethylamino)con-5-ene |
| (3b)-N,N-Dimethylcon-5-enin-3-amine |
| 3b-(Dimethylamino)con-5-enine |
| Con-5-enine, 3β- (dimethylamino)- |
| NERIINE |
| Con-5-enine, 3-β-(dimethylamino)- |
| 1-Deazaadenosine |
| 5-CONENIN-3BETA-DIMETHYLAMINE |
